Absolutely, CVBT/VT has epitomized what it means to progress as a biotech company. To celebrate the administration's seven-success since 2014, I have compiled a list highlighting some of their greatest achievements:
1. Lose every lawsuit to the former administration
2. Owe $1,000,000 to the former administration in a non-offsettable-judgement by the US Federal Court
3. Lose their legal representation because they had an inability to pay $200,000 in legal fees.
4. Have federal court records say that the company is completely valueless, has no revenue streams and no assets.
5. Has yet to make any progress what so ever in clinical trials.
6. Has yet to produce the drug they need for clinical trials
7. Has somehow downgraded their office space
8. Has signed a deal with a nobody company to secure the last $1 million dollars of the $100 million (if not more) that they need to raise.
9. Have their entire administration accused of fraud.
10. Have the CEO accused of embezzling money by the US Government
11. Have a known alcoholic run the PR at this forum.
12. File worthless patents
13. Attempting to sell highly-questionable convertible notes to innocent investors
Since this company is clearly moving in the right direction (if that direction is liquidation and bankruptcy), then why must our administration make fake news and try to argue that the stock is worth anything more than $0.01 per share, if that.
CVBT/VT is over. Expect another press release on this forum in another 6 months, maybe then they can raise a few pennies!
